ALPHAVAX
Dead / Cancelled — Cancelled — Section 8 (as of 19 Nov 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 75519184
- Registration number
- 2451403
- Mark type
- Word mark
- Filed
- 15 Jul 1998
- Published for opposition
- 07 Mar 2000
- Registered
- 15 May 2001
- Next maintenance due
- 15 May 2011
- Attorney of record
- Holly A. Coldiron
Goods and services
- Class 005 — Pharmaceuticals: viral-based vectors for use in the delivery of pharmaceutical and therapeutic drugs, vaccines and gene therapy
Owner
- ALPHAVAX, INC., RESEARCH TRIANGLE PARK, NC, US
- AlphaVax, LLC, Durham, NC, US
- AlphaVax, LLC, Durham, NC, US
- AlphaVax, LLC, Durham, NC, US
Prosecution history
- 19 Nov 2021 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 15 May 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 May 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 May 2011 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 May 2011 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 May 2011 — TEAS SECTION 8 & 9 RECEIVED
- 09 May 2007 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Apr 2007 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 10 Apr 2007 — TEAS SECTION 8 & 15 RECEIVED
- 06 Nov 2006 — CASE FILE IN TICRS
- 15 May 2001 — REGISTERED-PRINCIPAL REGISTER
- 02 Feb 2001 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Jan 2001 — ASSIGNED TO EXAMINER
- 28 Jan 2001 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Nov 2000 — USE AMENDMENT FILED